Sigyn Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2014 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Sigyn Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2014 to Q3 2024.
  • Sigyn Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 1.42M shares, a 96.8% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.42M -42.8M -96.8% Sep 30, 2024 10-Q 2024-11-19
Q2 2024 1.26M -43M -97.1% Jun 30, 2024 10-Q 2024-08-19
Q1 2024 1.22M -41.6M -97.1% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 1.29M +332K +34.7% Dec 31, 2023 10-Q 2024-11-19
Q3 2023 44.2M +6.94M +18.6% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 44.2M +6.94M +18.6% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 42.8M +5.51M +14.8% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 957K -36.3M -97.4% Dec 31, 2022 10-K 2024-02-20
Q3 2022 37.3M +567K +1.54% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 37.3M +671K +1.83% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 37.3M +2.05M +5.81% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 37.3M +2.09M +5.95% Dec 31, 2021 10-K 2023-03-31
Q3 2021 36.7M +36.2M +7246% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 36.6M -59.1M -61.8% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 35.2M -57.2M -61.9% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 35.2M +34.7M +6940% Dec 31, 2020 10-K 2022-03-21
Q3 2020 500K -80.8M -99.4% Sep 30, 2020 8-K/A 2020-12-30
Q2 2020 95.8M +14.5M +17.8% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 92.4M +11.2M +13.7% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 500K -80.8M -99.4% Dec 31, 2019 10-Q 2021-05-17
Q3 2019 81.3M +10.7M +15.1% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 81.3M +18.5M +29.4% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 81.3M +21.8M +36.6% Mar 31, 2019 10-Q 2019-04-19
Q4 2018 81.3M +28M +52.5% Dec 31, 2018 10-K 2020-03-30
Q3 2018 70.6M Sep 30, 2018 10-Q 2018-11-14
Q2 2018 62.8M Jun 30, 2018 10-Q 2018-08-13
Q1 2018 59.5M Mar 31, 2018 10-Q 2018-05-15
Q4 2017 53.3M Dec 31, 2017 10-K 2019-04-01
Q3 2016 34.5M +4.63M +15.5% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 34.4M Jun 30, 2016 10-Q 2016-08-04
Q1 2016 34.3M Mar 31, 2016 10-Q 2016-05-09
Q4 2015 34.3M +18.3M +115% Dec 31, 2015 10-Q 2016-11-14
Q3 2015 29.9M Sep 30, 2015 10-Q/A 2015-12-21
Q4 2014 16M Dec 31, 2014 10-Q 2020-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.